NASDAQ
NeuroSense Therapeutics Ltd. (NRSN) has a market cap of $20.37M as of Friday, May 22, 2026. The NRSN market cap is up 14.17% over the past 30 days and has declined 39.94% over the past year. Market capitalization represents the total market value of a company's outstanding shares, calculated by multiplying the stock price by the total number of shares outstanding.
No price data available for this timeframe.